Interleukin 2 (IL-2) production and expression of its membrane- bound receptor (IL-2R) are critical steps in the T-cell activation and clonal expansion that occurs in delayed-type hypersensitivity (DTH) reactions. A classic example of these DTH reactions are pulmonary granulomatous diseases, which are often highly destructive lesions that may require potent anti-inflammatory agents for effective treatment, these agents frequently compromise the patient's immunologic integrity. IL-2 is an important lymphokine in the pathogenesis of DTH reactions. Elucidation of regulatory mechanisms of IL-2 and IL-2R will lead to a better understanding of these diseases, as well as the mechanism, whereby IL-2 regulates DTH responses. Studies will begin with the effects of arachidonic acid metabolites on IL-2 production by the cloned human T-cell line Jurkat and the level of regulation addressed by quantitating IL-2 production and mRNA expression. Further studies will use a well-characterized model of T-cell-mediated synchronous granulomas, induced by embolization of Schistosoma mansoni eggs to the pulmonary vasculature. Changes in IL-2 production and IL-2R expression and their respective mRNA levels by cultured granuloma lymphocytes will be quantitated during the evolution of these lesions. Pharmacologic studies directed at the manipulation of cultured granuloma lymphocytes will assess alterations in normal IL-2 and IL-2R expression. These studies will use both a molecular and cellular approach to find optimal sensitivity and a therapeutic """"""""window"""""""" for effective suppression. Lymphocyte phenotypes, and IL-2R expression within the granuloma will be evaluated by both flow cytometry and immunoperoxidase allowing a precise quantitation of cell number and spatial relationships of lymphocytes. Granuloma development will be determined following treatment with exogenous human recombinant IL-2 and a monoclonal antibody directed against the IL-2R by: a) morphometric analysis of size, b) determination of lymphocyte populations, c) IL-2 production and, d) IL-2R expression. Using the techniques of molecular biology, flow cytometry, immunoperoxidase and quantitative morphometry, the central roles of IL-2 and IL-2R in regulating pulmonary granulomatous inflammation will be carefully dissected.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29HL039339-03
Application #
3471614
Study Section
Pathology A Study Section (PTHA)
Project Start
1988-04-01
Project End
1991-03-31
Budget Start
1990-04-01
Budget End
1991-03-31
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Eskandari, M K; Bolgos, G; Miller, C et al. (1992) Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J Immunol 148:2724-30
Lin, H; Chensue, S W; Strieter, R M et al. (1992) Antibodies against tumor necrosis factor prolong cardiac allograft survival in the rat. J Heart Lung Transplant 11:330-5
Coran, A G; Drongowski, R A; Paik, J J et al. (1992) Ibuprofen intervention in canine septic shock: reduction of pathophysiology without decreased cytokines. J Surg Res 53:272-9
Ulich, T R; Guo, K Z; Remick, D et al. (1991) Endotoxin-induced cytokine gene expression in vivo. III. IL-6 mRNA and serum protein expression and the in vivo hematologic effects of IL-6. J Immunol 146:2316-23
Martin, L F; Vary, T C; Davis, P K et al. (1991) Intravascular plastic catheters. How they potentiate tumor necrosis factor release and exacerbate complications associated with sepsis. Arch Surg 126:1087-93
Remick, D G; Nguyen, D T; Eskandari, M K et al. (1991) Interleukin 2 induces tumor necrosis factor gene expression in vivo. Immunol Invest 20:395-405
DeForge, L E; Remick, D G (1991) Sandwich ELISA for detection of picogram quantities of interleukin-8. Immunol Invest 20:89-97
DeForge, L E; Nguyen, D T; Kunkel, S L et al. (1990) Regulation of the pathophysiology of tumor necrosis factor. J Lab Clin Med 116:429-38
Remick, D G; Kunkel, S L; Holbrook, E A et al. (1990) Theory and applications of the polymerase chain reaction. Am J Clin Pathol 93:S49-54
Spengler, R N; Spengler, M L; Lincoln, P et al. (1989) Dynamics of dibutyryl cyclic AMP- and prostaglandin E2-mediated suppression of lipopolysaccharide-induced tumor necrosis factor alpha gene expression. Infect Immun 57:2837-41

Showing the most recent 10 out of 11 publications